Sérgio Hofmeister Martins-Costa

Sérgio Hofmeister Martins-Costa

Auto-generated profile, based on publicly available information

Sérgio Hofmeister Martins-Costa

Department of Gynecology and Obstetrics, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Pregnancy Hypertension
Verified
Journal Article
Closed access
MCMaria Teresa Pedrazzi Chaves
Maria Teresa Pedrazzi Chaves
SMSérgio Martins-Costa
Sérgio Martins-Costa
MOMaria Lúcia da Rocha Oppermann
Maria Lúcia da Rocha Oppermann
RDRicardo Palma Dias
Ricardo Palma Dias
VMValentino Magno
Valentino Magno
JRJosé Geraldo Lopes Ramos
José Geraldo Lopes Ramos

1 May 2023 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
ADAmanda Dantas-Silva
Amanda Dantas-Silva
FSFernanda Surita
Fernanda Surita
RSRenato Souza
Renato Souza
LRLeila Rocha
Leila Rocha
JGJosé Paulo Guida
José Paulo Guida
MCMaria Laura Costa
Maria Laura Costa
Objective To evaluate the impact of the race (Black versus non-Black) on maternal and perinatal outcomes of pregnant women with COVID-19 in Brazil. Methods This is a subanalysis of REBRACO, a Brazilian multicenter cohort study designed to evaluate the impact of COVID-19 on pregnant women. From February 2020 until February 2021, 15 maternity hospitals in Brazil collected data on women with respiratory symptoms. We selected all women with a positive test for COVID-19; then, we divided them into two groups: Black and non-Black women. Finally, we compared, between groups, sociodemographic, maternal, and perinatal outcomes. We obtained the frequency of events in each group and compared them using X2 test; p-values < 0.05 were considered significant. We also estimated the odds ratio (OR) and confidence intervals (CI). Results 729 symptomatic women were included in the study; of those, 285 were positive for COVID-19, 120 (42.1%) were Black, and 165 (57.9%) were non-Black. Black women had worse education (p = 0.037). The timing of access to the health system was similar between both groups, with 26.3% being included with seven or more days of symptoms. Severe acute respiratory syndrome (OR 2.22 CI 1.17–4.21), intensive care unit admission (OR 2.00 CI 1.07–3.74), and desaturation at admission (OR 3.72 CI 1.41–9.84) were more likely to occur among Black women. Maternal death was higher among Black women (7.8% vs. 2.6%, p = 0.048). Perinatal outcomes were similar between both groups. Conclusion Brazilian Black women were more likely to die due to the consequences of COVID-19.

1 September 2021 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
JVJanete Vettorazzi
Janete Vettorazzi
EVEdimárlei Gonsales Valério
Edimárlei Gonsales Valério
MZMaria Alexandrina Zanatta
Maria Alexandrina Zanatta
MSMariana Hollmann Scheffler
Mariana Hollmann Scheffler
SCSergio Hofmeister de Almeida Martins Costa
Sergio Hofmeister de Almeida Martins Costa
JRJosé Geraldo Lopes Ramos
José Geraldo Lopes Ramos
Objective To determine the profile of maternal deaths occurred in the period between 2000 and 2019 in the Hospital de Clínicas de Porto Alegre (HCPA, in the Portuguese acronym) and to compare it with maternal deaths between 1980 and 1999 in the same institution. Methods Retrospective study that analyzed 2,481 medical records of women between 10 and 49 years old who died between 2000 and 2018. The present study was approved by the Ethics Committee (CAAE 78021417600005327). Results After reviewing 2,481 medical records of women who died in reproductive age, 43 deaths had occurred during pregnancy or in the postpartum period. Of these, 28 were considered maternal deaths. The maternal mortality ratio was 37.6 per 100,000 live births. Regarding causes, 16 deaths (57.1%) were directly associated with pregnancy, 10 (35.1%) were indirectly associated, and 2 (7.1%) were unrelated. The main cause of death was hypertension during pregnancy (31.2%) followed by acute liver steatosis during pregnancy (25%). In the previous study, published in 2003 in the same institution4, the mortality rate was 129 per 100,000 live births, and most deaths were related to direct obstetric causes (62%). The main causes of death in this period were due to hypertensive complications (17.2%), followed by postcesarean infection (16%). Conclusion Compared with data before the decade of 2000, there was an important reduction in maternal deaths due to infectious causes. Objetivo Determinar o perfil dos óbitos maternos ocorridos no período de 2000 a 2019 no Hospital de Clínicas de Porto Alegre (HCPA) e comparar com os óbitos maternos entre 1980 e 1999 na mesma instituição. Métodos Estudo retrospectivo que analisou 2.400 prontuários de mulheres entre 10 e 49 anos que morreram entre 2000 e 2019. O presente estudo foi aprovado pelo Comitê de Ética (CAAE 78021417600005327). Resultados Após revisão de 2.481 prontuários de mulheres que morreram em idade reprodutiva, 43 mortes ocorreram durante a gravidez ou no período pós-parto. Destas, 28 foram considerados óbitos maternos. A taxa de mortalidade materna foi de 37.6 por 100.000 nascidos vivos. Em relação às causas, 16 óbitos (57.1%) estiveram diretamente associados à gravidez, 10 (35.1%) estiveram indiretamente associados e 2 (7.1%) não estiveram relacionados. A principal causa de morte foi hipertensão na gravidez (31.2%) seguida de esteatose hepática aguda da gravidez (25%). No estudo anterior, publicado em 2003 na mesma instituição4, a taxa de mortalidade foi de 129 por 100.000 nascidos vivos, e a maioria dos óbitos estava relacionada a causas obstétricas diretas (62%). As principais causas de óbito neste período foram por complicações hipertensivas (17.2%), seguidas de infecção pós-cesárea (16%). Conclusão Em comparação com os dados anteriores à década de 2000, houve uma redução importante das mortes maternas por causas infecciosas. All authors contributed with the project and data interpretation, the writing of the article, the critical review of the intellectual content, and with the final approval of the version to be published. Received: 17 December 2020 Accepted: 02 August 2021 Article published online: 20 October 2021 © 2021. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

3 June 2024 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
HKHenri Augusto Korkes
Henri Augusto Korkes
RCRicardo Carvalho Cavalli
Ricardo Carvalho Cavalli
LOLeandro Gustavo De Oliveira
Leandro Gustavo De Oliveira
JRJosé Geraldo Lopes Ramos
José Geraldo Lopes Ramos
SCSérgio Hofmeister de Almeida Martins Costa
Sérgio Hofmeister de Almeida Martins Costa
MCMaria Laura Costa
Maria Laura Costa
In low and middle-income countries such as Brazil, most maternal deaths are related to hypertensive complications. Preeclampsia is the leading cause of maternal mortality and morbidity. Significant proportion is associated with the following factors: lack of identification of high-risk women, lack of adequate prevention, difficulty in maintaining a high-risk prenatal follow-up, delayed diagnosis, insecurity […] Abstract In low and middle-income countries such as Brazil, most maternal deaths are related to hypertensive complications. Preeclampsia is the leading cause of maternal mortality and morbidity. Significant proportion is associated with the following factors: lack of identification of high-risk women, lack of adequate prevention, difficulty in maintaining a high-risk prenatal follow-up, delayed diagnosis, insecurity […]

1 July 2022 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
JRJosé Geraldo Lopes Ramos
José Geraldo Lopes Ramos
SMSérgio Hofmeister Martins-Costa
Sérgio Hofmeister Martins-Costa
NSNelson Sass
Nelson Sass
Recently, Bartal and Sibai[1] wrote about the current concepts of eclampsia in the 21st Century. One of the several interesting points of this article is the comparison of the incidence of eclampsia between developed countries and countries with low socioeconomic status. The eclampsia rate per 10,000 births ranged around 150.6 in Madagascar, 140.1 in Tanzania and 50.2 in India. When comparing these numbers with those of developed countries, we see incredible lower rates such as 8.6 in Australia, 8.4 in Canada, 3.4 in the US, 2.7 in the UK and 1.5 in Finland. Guida et al.[2] analyzed data on the prevalence of eclampsia in Brazil. The cumulative frequency of hypertensive disease during pregnancy was 6.7%, which is similar to other countries. They found a frequency of eclampsia of 1.7 to 6.2% in hypertensive pregnant women. Of the 10 studies analyzed, 3 reported the occurrence of eclampsia. In these 3 series, we had 42,220 births and an eclampsia rate of 10.42 per 10,000 births. These data point to an eclampsia rate similar to Australia or Canada, but higher than in countries such as the UK and Finland.[1] When we analyze the ratios of general maternal mortality and death from hypertension and eclampsia in Brazil, we see that we still have a lot to improve. Using data from DATASUS,[3] which are the official data for Brazil and have been properly computed for many years, we found that the maternal mortality ratios due to hypertension have not changed from 2015 to 2019 ([Fig. 1]). We used the data up to 2019 because they are the last published and revised data that have not yet been contaminated by the mortality of the COVID-19 pandemic. In the comparative analysis of general maternal mortality, from hypertension and from eclampsia, we found an important difference between the Brazilian regions ([Fig. 2]). The chance of death from eclampsia is 3 times higher in the northern region when compared with the southern region (odds ratio, OR = 3.26; 95% confidence interval, CI: 2.02–5.27) ([Fig. 3]). The difference in mortality from hypertension during pregnancy among the Brazilians regions is very significant. The eclampsia mortality ratio ranged from 11.47 in the northern region to 2.07 per 100,000 live births in 2019 in the south region ([Fig. 2]). In the comparative analysis with data from Bartal and Sibai,[1] we found a mortality rate due to eclampsia that managed to be almost zero in some countries. We believe that the differences in eclampsia incidence and complication rates can be significantly reduced with simple, accessible, and already well-known health measures. Early access to prenatal care, adequate prenatal care, the use of protocols for the management of hypertension and eclampsia, early hospitalization of preeclampsia, indication of pregnancy resolution in cases of preeclampsia with signs of severity or close to term, the prescription of low-dose ASA and calcium supplements for pregnant women at risk for preeclampsia, prophylaxis of eclampsia with magnesium sulfate supplements in the peripartum and antihypertensive treatment are important measures. These measures have a high impact on maternal health and do not require the use of expensive or inaccessible technology. Brazil is immense and with different regional realities in its territories. Locations with greater socioeconomic vulnerability need to be supported and receive customized care for the reduction of their indicators to be achieved. Although the pathophysiology of preeclampsia has not yet been fully understood and its complete prevention is a difficult task, the occurrence of eclampsia and its consequences can and should be avoided. In the 21st century, we know what to do to treat hypertension during pregnancy and eradicate the deaths caused by it. Doctors gathered in the Brazilian Network for Studies on Hypertension in Pregnancy (RBEHG) have proposed projects with the objective of achieving “zero maternal deaths from hypertension.” The Brazilian Federation of Gynecology and Obstetrics Associations (FEBRASGO), with its continuing education, has been discussing eclampsia in many Congresses and issuing very adequate Protocols, seeking to shed a light on this serious national problem. It is time that risk ranking systems actually work in Brazil and that health care providers for pregnant women (clinicians, family doctors, obstetricians, and nurses) commit to engaging with protocols. Those protocols are already widely known. Despite the difficulties, it encourages us to know that effective and cost-effective actions can be optimized depending on collaboration and an agreement that can guarantee greater safety for all our pregnant women. Article published online: 08 August 2022 © 2022. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil